Style | Citing Format |
---|---|
MLA | Feyisa SG, et al.. "Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated From Hiv Seropositive Patients in Tehran Iran." Current HIV Research, vol. 19, no. 4, 2021, pp. 295-303. |
APA | Feyisa SG, Rasoolinejad M, Hasannejad M, Amini S, Hamzelou G, Kardanyamchi J, Kazemian H, Karamizarandi M, Feizabadi MM (2021). Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated From Hiv Seropositive Patients in Tehran Iran. Current HIV Research, 19(4), 295-303. |
Chicago | Feyisa SG, Rasoolinejad M, Hasannejad M, Amini S, Hamzelou G, Kardanyamchi J, Kazemian H, Karamizarandi M, Feizabadi MM. "Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated From Hiv Seropositive Patients in Tehran Iran." Current HIV Research 19, no. 4 (2021): 295-303. |
Harvard | Feyisa SG et al. (2021) 'Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated From Hiv Seropositive Patients in Tehran Iran', Current HIV Research, 19(4), pp. 295-303. |
Vancouver | Feyisa SG, Rasoolinejad M, Hasannejad M, Amini S, Hamzelou G, Kardanyamchi J, et al.. Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated From Hiv Seropositive Patients in Tehran Iran. Current HIV Research. 2021;19(4):295-303. |
BibTex | @article{ author = {Feyisa SG and Rasoolinejad M and Hasannejad M and Amini S and Hamzelou G and Kardanyamchi J and Kazemian H and Karamizarandi M and Feizabadi MM}, title = {Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated From Hiv Seropositive Patients in Tehran Iran}, journal = {Current HIV Research}, volume = {19}, number = {4}, pages = {295-303}, year = {2021} } |
RIS | TY - JOUR AU - Feyisa SG AU - Rasoolinejad M AU - Hasannejad M AU - Amini S AU - Hamzelou G AU - Kardanyamchi J AU - Kazemian H AU - Karamizarandi M AU - Feizabadi MM TI - Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated From Hiv Seropositive Patients in Tehran Iran JO - Current HIV Research VL - 19 IS - 4 SP - 295 EP - 303 PY - 2021 ER - |